SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Shares Up 2.8% – Here’s Why

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) shares traded up 2.8% during mid-day trading on Thursday . The company traded as high as $67.17 and last traded at $67.16. Approximately 87,085 shares were traded during trading, an increase of 5% from the average session volume of 83,059 shares. The stock had previously closed at $65.32.

SPDR S&P Pharmaceuticals ETF Trading Up 2.8%

The firm has a market cap of $409.68 million, a PE ratio of 14.28 and a beta of 0.58. The stock has a fifty day simple moving average of $59.49 and a two-hundred day simple moving average of $57.21.

Hedge Funds Weigh In On SPDR S&P Pharmaceuticals ETF

A number of large investors have recently modified their holdings of XPH. Turtle Creek Wealth Advisors LLC purchased a new position in SPDR S&P Pharmaceuticals ETF during the first quarter valued at approximately $26,000. Western Wealth Management LLC bought a new stake in SPDR S&P Pharmaceuticals ETF during the 1st quarter worth approximately $34,000. Advisory Services Network LLC purchased a new stake in SPDR S&P Pharmaceuticals ETF in the 3rd quarter worth approximately $34,000. Fifth Third Bancorp purchased a new stake in SPDR S&P Pharmaceuticals ETF in the 1st quarter worth approximately $39,000. Finally, Team Financial Group LLC bought a new position in SPDR S&P Pharmaceuticals ETF in the 4th quarter valued at $56,000.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.